Medicare Part D 2017 Formulary Changes OC Preferred

Size: px
Start display at page:

Download "Medicare Part D 2017 Formulary Changes OC Preferred"

Transcription

1 Medicare Part D 017 Formulary s OC Preferred Inter Valley Health Plan may add or remove drugs from our formulary during the year. If we remove a drug from our formulary, add prior authorization, quantity limits and/or step therapy restrictions or move a drug to a higher cost-sharing tier, we will notify you of the change at least 60 days before the date that the change becomes effective. However, if the U.S. Food and Drug Administration (FDA) determines a drug on our formulary to be unsafe or the drug s manufacturer removes the drug from the market, we will immediately remove the drug from our formulary. The table below outlines changes made to our formulary throughout 017. VERSION: FORMULARY ADDITIONS UPDATE AS OF AUGUST 1, 017: FORMULARY ID: Formulary additions, reductions in preferred or tiered cost-sharing status, or removal of Utilization Management to an existing formulary drug Covered Drug Name ALUNBRIG TAB 30MG BRIGATINIB ADDITION 8/1/017 5 PA CLOFARABINE INJ 0/0ML CLOLAR ADDITION 8/1/017 5 PA EZETIM/SIMVA TAB 10-10MG VYTORIN ADDITION 8/1/017 QL (30 PER 30 DAYS), (90) EZETIM/SIMVA TAB 10-0MG VYTORIN ADDITION 8/1/017 QL (30 PER 30 DAYS), (90) EZETIM/SIMVA TAB 10-80MG VYTORIN ADDITION 8/1/017 QL (30 PER 30 DAYS), (90) IMFINZI INJ 10/.4 DURVALUMAB ADDITION 8/1/017 5 PA IMFINZI INJ 500/10 DURVALUMAB ADDITION 8/1/017 5 PA KISQALI 00 PAK FEMARA RIBOCICLIB AND LETROZOLE ADDITION 8/1/017 5 PA KISQALI 400 PAK FEMARA RIBOCICLIB AND LETROZOLE ADDITION 8/1/017 5 PA 1

2 KISQALI 600 PAK FEMARA RIBOCICLIB AND LETROZOLE ADDITION 8/1/017 5 PA RYDAPT CAP 5MG MIDOSTAURIN ADDITION 8/1/017 5 PA XATMEP SOL.5MG/ML METHOTREXATE ADDITION 8/1/017 5 PA ZEJULA CAP 100MG NIRAPARIB ADDITION 8/1/017 5 PA GARDASIL INJ PAPILLOMAVIRUS VACCINE DELETION 8/1/017 4 PA PEG-INTRON KIT 150 RP PEGINTERFERON ALFA-b DELETION 8/1/017 5 QL (4 PER 8 DAYS), PA PEG-INTRON KIT 50MCG RP PEGINTERFERON ALFA-b DELETION 8/1/017 5 QL (4 PER 8 DAYS), PA PEG-INTRON KIT 80MCG RP PEGINTERFERON ALFA-b DELETION 8/1/017 5 QL (4 PER 8 DAYS), PA BAVENCIO INJ 0MG/ML AVELUMAB ADDITION 7/1/017 5 PA PRISTIQ DESVENLAFAX TAB 100MG ER ADDITION 7/1/017 QL (30 PER 30 DAYS) DESVENLAFAX TAB 5MG ER PRISTIQ ADDITION 7/1/017 QL (40 PER 30 DAYS) DESVENLAFAX TAB 50MG ER PRISTIQ ADDITION 7/1/017 QL (40 PER 30 DAYS) PIRFENIDONE 5 ESBRIET TAB 67MG ADDITION 7/1/017 QL (70 PER 30 DAYS), PA ESBRIET TAB 801MG PIRFENIDONE ADDITION 7/1/017 5 QL (90 PER 30 DAYS), PA LEVOLEUCOVOR INJ 50MG FUSILEV ADDITION 7/1/017 4 PA NITROGLYCERN SUB 0.3MG NITROSTAT ADDITION 7/1/017 OSELTAMIVIR CAP 30MG TAMIFLU ADDITION 7/1/017 QL (84 PER 180 DAYS) OSELTAMIVIR CAP 45MG TAMIFLU ADDITION 7/1/017 QL (4 PER 180 DAYS) OSELTAMIVIR CAP 75MG TAMIFLU ADDITION 7/1/017 QL (4 PER 180 DAYS) VIRAZOLE INH 6GM RIBAVIRIN DELETION 7/1/017 5 PA BUTRANS DIS 10MCG/HR BUPRENORPHINE ADDITION 6/1/017 3 QL (4 PER 8 DAYS) BUTRANS DIS 15MCG/HR BUPRENORPHINE ADDITION 6/1/017 3 QL (4 PER 8 DAYS) BUTRANS DIS 0MCG/HR BUPRENORPHINE ADDITION 6/1/017 3 QL (4 PER 8 DAYS) BUTRANS DIS 5MCG/HR BUPRENORPHINE ADDITION 6/1/017 3 QL (4 PER 8 DAYS) BUTRANS DIS 7.5/HR BUPRENORPHINE ADDITION 6/1/017 3 QL (4 PER 8 DAYS)

3 BYDUREON INJ BYDUREON INJ EXENATIDE EXTENDED RELEASE EXENATIDE EXTENDED RELEASE REDUCTION 6/1/017 3 QL (4 PER 8 DAYS) REDUCTION 6/1/017 3 QL (4 PER 8 DAYS) FARXIGA TAB 10MG DAPAGLIFLOZIN ADDITION 6/1/017 3 FARXIGA TAB 5MG DAPAGLIFLOZIN ADDITION 6/1/017 3 FLECTOR DIS 1.3% DICLOFENAC ADDITION 6/1/017 3 HYSINGLA ER TAB 100 MG HYSINGLA ER TAB 10 MG HYSINGLA ER TAB 0 MG HYSINGLA ER TAB 30 MG HYSINGLA ER TAB 40 MG HYSINGLA ER TAB 60 MG HYSINGLA ER TAB 80 MG KISQALI TAB 00DOSE RIBOCICLIB ADDITION 6/1/017 5 PA KISQALI TAB 400DOSE RIBOCICLIB ADDITION 6/1/017 5 PA KISQALI TAB 600DOSE RIBOCICLIB ADDITION 6/1/017 5 PA OXYCONTIN TAB 10MG CR OXYCONTIN TAB 15MG CR 3

4 OXYCONTIN TAB 0MG CR OXYCONTIN TAB 30MG CR OXYCONTIN TAB 40MG CR OXYCONTIN TAB 60MG CR OXYCONTIN TAB 80MG CR TRULICITY INJ 0.75/0.5 DULAGLUTIDE ADDITION 6/1/017 3 QL ( PER 8 DAYS) TRULICITY INJ 1.5/0.5 DULAGLUTIDE ADDITION 6/1/017 3 QL ( PER 8 DAYS) XIGDUO XR TAB DAPAGLIFLOZIN AND METFORMIN EXTENDED- RELEASE ADDITION 6/1/017 3 XIGDUO XR TAB MG DAPAGLIFLOZIN AND METFORMIN EXTENDED- RELEASE ADDITION 6/1/017 3 XIGDUO XR TAB MG DAPAGLIFLOZIN AND METFORMIN EXTENDED- RELEASE ADDITION 6/1/017 3 XIGDUO XR TAB 5-500MG DAPAGLIFLOZIN AND METFORMIN EXTENDED- RELEASE ADDITION 6/1/017 3 SELZENTRY TAB 5MG MARAVIROC ADDITION 5/1/017 5 SELZENTRY TAB 75MG MARAVIROC ADDITION 5/1/017 5 APREPITANT CAP 40MG EMEND ADDITION 5/1/017 QL (30 PER 30 DAYS), PA APREPITANT CAP 80MG EMEND ADDITION 5/1/017 QL (30 PER 30 DAYS), PA 4

5 APREPITANT CAP 15MG EMEND ADDITION 5/1/017 QL (30 PER 30 DAYS), PA MIRCERA INJ 50MCG METHOXY POLYETHYLENE GLYCOL-EPOETIN BETA ADDITION 5/1/017 4 PA MIRCERA INJ 75MCG METHOXY POLYETHYLENE GLYCOL-EPOETIN BETA ADDITION 5/1/017 4 PA MIRCERA INJ 100MCG METHOXY POLYETHYLENE GLYCOL-EPOETIN BETA ADDITION 5/1/017 4 PA MIRCERA INJ 00MCG METHOXY POLYETHYLENE GLYCOL-EPOETIN BETA ADDITION 5/1/017 4 PA ASA/DIPYRIDA CAP 5-00MG AGGRENOX ADDITION 5/1/017 QL (60 PER 30 DAYS) AMIFOSTINE INJ 500MG AMIFOSTINE DELETION 4/1/017 5 PA AMIODARONE TAB 100MG PACERONE ADDITION 4/1/017 DOXYCYCL HYC INJ 100MG DOXY DELETION 4/1/017 PA LOPIN/RITON SOL 80-0/ML KALETRA ADDITION 4/1/017 QL (480 PER 30 DAYS) MENOMUNE INJ A/C/Y/W MENINGOCOCCAL POLYSACCHARIDE VACCINE DELETION 4/1/017 4 NECON TAB 1/35 ETHINYL ESTRADIOL AND NORETHINDRONE DELETION 4/1/ MOP CAP 10MG METHOXSALEN DELETION 3/1/017 3 PA ABACA/LAMIVU TAB EPZICOM ADDITION 3/1/017 QL (30 PER 30 DAYS) A-HYDROCORT INJ 100MG CORTEF DELETION 3/1/017 PA BUPROBAN TAB 150MG BUPROPION DELETION 3/1/017 QL (90 PER 30 DAYS) CERVARIX INJ HUMAN PAPILLOMAVIRUS (HPV) BIVALENT(TYPES 16,18) RECMB VAC DELETION 3/1/017 4 DOCEFREZ INJ 0MG DOCETAXEL DELETION 3/1/017 5 PA ERGOMAR SUB MG ERGOTAMINE DELETION 3/1/017 5

6 EZETIMIBE TAB 10MG ZETIA ADDITION 3/1/017 QL (30 PER 30 DAYS) GENGRAF CAP 50MG NEORAL ADDITION 3/1/017 PA KYPROLIS SOL 30MG CARFILZOMB ADDITION 3/1/017 5 PA KYPROLIS SOL 60MG CARFILZOMB ADDITION 3/1/017 5 PA LANTUS INJ SOLOSTAR INSULIN GLARGINE ADDITION 3/1/017 3 QL (30 PER 30 DAYS) LARTRUVO INJ 10MG/ML OLARATUMAB ADDITION 3/1/017 5 PA MENEST TAB.5MG ESTERIFIED ESTROGENS DELETION 3/1/017 METHOTREXATE INJ 5MG/ML METHOTREXATE ADDITION 3/1/017 PA NAPHAZOLINE SOL 0.1% OP NAPHAZOLINE DELETION 3/1/017 1 NIFEDICAL XL TAB 30MG PROCARDIA XL, ADALAT CC DELETION 3/1/017 NIFEDICAL XL TAB 60MG PROCARDIA XL, ADALAT CC DELETION 3/1/017 NILUTAMIDE TAB 150MG NILANDRON ADDITION 3/1/017 QL (30 PER 30 DAYS) RANITIDINE INJ 150/6ML ZANTAC DELETION 3/1/017 PA RASAGILINE TAB 0.5MG AZILECT ADDITION 3/1/017 RASAGILINE TAB 1MG AZILECT ADDITION 3/1/017 ROSUVASTATIN TAB 10MG CRESTOR ADDITION 3/1/017 QL (30 PER 30 DAYS), (90) ROSUVASTATIN TAB 0MG CRESTOR ADDITION 3/1/017 QL (30 PER 30 DAYS), (90) ROSUVASTATIN TAB 40MG CRESTOR ADDITION 3/1/017 QL (30 PER 30 DAYS), (90) ROSUVASTATIN TAB 5MG CRESTOR ADDITION 3/1/017 QL (30 PER 30 DAYS), (90) RUBRACA TAB 00MG RUCAPARIB ADDITION 3/1/017 5 PA RUBRACA TAB 300MG RUCAPARIB ADDITION 3/1/017 5 PA STAVUDINE SOL 1MG/ML ZERIT DELETION 3/1/017 QL (400 PER 30 DAYS) TRAVOPROST DRO 0.004% TRAVATAN DELETION 3/1/017 TYZEKA TAB 600MG TELBIVUDINE DELETION 3/1/017 5 PA 6

7 VITEKTA TAB 150MG ELVITEGRAVIR DELETION 3/1/017 5 QL (30 PER 30 DAYS) VITEKTA TAB 85MG ELVITEGRAVIR DELETION 3/1/017 5 QL (30 PER 30 DAYS) XIIDRA DRO 5% LIFITEGRAST ADDITION 3/1/017 4 QL (60 PER 30 DAYS) YONDELIS INJ 1MG TRABECTEDIN ADDITION 3/1/017 5 PA ZERIT SOL 1MG/ML STAVUDINE ADDITION 3/1/017 4 QL (400 PER 30 DAYS) 7

8 8

Medicare Part D 2017 Formulary Changes Service To Senior

Medicare Part D 2017 Formulary Changes Service To Senior Medicare Part D 2017 Formulary s Service To Senior Inter Valley Health Plan may add or remove drugs from our formulary during the year. If we remove a drug from our formulary, add prior authorization,

More information

Medicare Part D 2017 Formulary Changes OC Preferred

Medicare Part D 2017 Formulary Changes OC Preferred Medicare Part D 2017 Formulary Changes OC Preferred Inter Valley Health Plan may add or remove drugs from our formulary during the year. If we remove a drug from our formulary, add prior authorization,

More information

Medicare Part D 2017 Formulary Changes OC Preferred

Medicare Part D 2017 Formulary Changes OC Preferred Medicare Part D 2017 Formulary s OC Preferred Inter Valley Health Plan may add or remove drugs from our formulary during the year. If we remove a drug from our formulary, add prior authorization, quantity

More information

Medicare Part D 2017 Formulary Changes Service To Senior

Medicare Part D 2017 Formulary Changes Service To Senior Medicare Part D 2017 Formulary Changes Service To Senior Inter Valley Health Plan may add or remove drugs from our formulary during the year. If we remove a drug from our formulary, add prior authorization,

More information

VIVA MEDICARE IMPORTANT T EXPANDED PERFORMANCE FORMULARY UPDATES

VIVA MEDICARE IMPORTANT T EXPANDED PERFORMANCE FORMULARY UPDATES NORE/ETH/FER CHW 0.MG Added to the 07 //07 ALYACEN TAB / Added to the 07 //07 AMETHIA LO TAB Added to the 07 //07 ERGOT/CAFFEN TAB 00MG Added to the 07 //07 NORETH/ETHIN TAB /0 Added to the 07 //07 LORCET

More information

2017 Medicare Part D Formulary Change

2017 Medicare Part D Formulary Change 2017 Medicare Part D Formulary Change We may add or remove drugs from our formulary during the year. If we remove drugs from our formulary, or add prior authorizations, quantity limits and/or step therapy

More information

2017 Medicare Part D Formulary Change

2017 Medicare Part D Formulary Change 2017 Medicare Part D Formulary Change We may add or remove drugs from our formulary during the year. If we remove drugs from our formulary, or add prior authorizations, quantity limits and/or step therapy

More information

2017 Medicare Part D Formulary Change

2017 Medicare Part D Formulary Change 2017 Medicare Part D Formulary Change We may add or remove drugs from our formulary during the year. If we remove drugs from our formulary, or add prior authorizations, quantity limits and/or step therapy

More information

Partners Notice of Change March 2017

Partners Notice of Change March 2017 New Added Products: Effective 3/1/2017 Drug Reason Tier Restrictions abacavir 600 mg-lamivudine 300 QL ADRENACLICK 0.15 MG/0.15 ML INJECTION,AUTO- INJECTOR ADRENACLICK 0.3 MG/0.3 ML INJECTION, AUTO- INJECTOR

More information

2017 Formulary Addendum Notice of Change

2017 Formulary Addendum Notice of Change 017 Formulary Addendum Notice of Change (Medicare Advantage Plans) WellCare Health Plans WellCare Choice (HMO), WellCare Essential (HMO-POS), WellCare Value (HMO) This is a listing of the changes that

More information

2017 Formulary Addendum Notice of Change (Prescription Drug Plans)

2017 Formulary Addendum Notice of Change (Prescription Drug Plans) 2017 Formulary Addendum Notice of Change (Prescription Drug Plans) WellCare Prescription Insurance, Inc. WellCare Classic (PDP) WellCare Extra (PDP) This is a listing of the changes that have occurred

More information

2017 Formulary Addendum Notice of Change

2017 Formulary Addendum Notice of Change 2017 Formulary Addendum Notice of Change (Prescription Drug Plans) WellCare Prescription Insurance, Inc. WellCare Classic (PDP) WellCare Extra (PDP) This is a listing of the changes that have occurred

More information

2017 Formulary Addendum Notice of Change

2017 Formulary Addendum Notice of Change 2017 Formulary Addendum Notice of Change (Medicare Advantage Plans) WellCare Health Plans WellCare Access (HMO SNP), WellCare Liberty (HMO SNP), WellCare Reserve (HMO), WellCare Rx (HMO), WellCare Select

More information

2017 Formulary Changes Year to Date

2017 Formulary Changes Year to Date 2017 Formulary Changes Year to Date Health Choice Arizona may add or remove drugs from our formulary during the year. If we remove drugs from our formulary, add prior authorization, quantity limits and/or

More information

Medicare Part D 2012 Formulary Changes Service To Senior and Total Fit

Medicare Part D 2012 Formulary Changes Service To Senior and Total Fit Medicare Part D 2012 Formulary s Service To Senior and Total Fit Inter Valley Health Plan may add or remove drugs from our formulary during the year. If we remove a drug from our formulary, add prior authorization,

More information

2017 Formulary Addendum Notice of Change (Medicare Advantage Plans)

2017 Formulary Addendum Notice of Change (Medicare Advantage Plans) 2017 Formulary Addendum Notice of Change (Medicare Advantage Plans) Easy Choice Health Plan Easy Choice Freedom Plan (HMO SNP) H5087-001 This is a listing of the changes that have occurred in our formulary.

More information

2017 Formulary Addendum Notice of Change (Medicare Advantage Plans)

2017 Formulary Addendum Notice of Change (Medicare Advantage Plans) 207 Formulary Addendum Notice of Change (Medicare Advantage Plans) Easy Choice Health Plan Easy Choice Plus Plan (HMO) H5087-002, H5087-07 This is a listing of the changes that have occurred in our formulary.

More information

2017 Formulary Addendum Notice of Change (Medicare Advantage Plans)

2017 Formulary Addendum Notice of Change (Medicare Advantage Plans) 2017 Formulary Addendum Notice of Change (Medicare Advantage Plans) Easy Choice Health Plan Easy Choice Best Plan (HMO) H5087-005 This is a listing of the changes that have occurred in our formulary. Please

More information

Medicare Part D 2016 Formulary Changes Service To Senior and OC Preferred

Medicare Part D 2016 Formulary Changes Service To Senior and OC Preferred Medicare Part D 2016 Formulary s Service To Senior and OC Preferred Inter Valley Health Plan may add or remove drugs from our formulary during the year. If we remove a drug from our formulary, add prior

More information

Changes to the 2018 BlueCross Secure SM (HMO) & BlueCross Total SM (PPO) Formularies

Changes to the 2018 BlueCross Secure SM (HMO) & BlueCross Total SM (PPO) Formularies Changes to the 2018 BlueCross Secure SM (HMO) & BlueCross Total SM (PPO) Formularies BlueCross BlueShield of South Carolina may add or remove drugs from the formulary during the year. If we remove drugs

More information

2018 Formulary Notice of Change Prescription Drug Plans

2018 Formulary Notice of Change Prescription Drug Plans 2018 Formulary Notice of Change Prescription Drug Plans WellCare Prescription Insurance, Inc. Plans in all states: WellCare Classic (PDP) WellCare may add or remove drugs from our formulary during the

More information

Health Partners Medicare Special (2017) Updates

Health Partners Medicare Special (2017) Updates March 2017 Effective Date Brand Name EVZIO erythromycin ethylsuccinate naloxone hcl Generic Name erythromycin ethylsuccinate Type of Change Previous Value New Value ofloxacin ofloxacin NAMZARIC NAMZARIC

More information

2018 Medicare Part D Formulary Change

2018 Medicare Part D Formulary Change 2018 Medicare Part D Formulary Change We may add or remove drugs from our formulary during the year. If we remove drugs from our formulary, or add prior authorizations, quantity limits and/or step therapy

More information

Aetna Better Health Illinois Premier Plan. November 2015 Formulary Updates. October 2015 Formulary Updates

Aetna Better Health Illinois Premier Plan. November 2015 Formulary Updates. October 2015 Formulary Updates Aetna Better Health Illinois Premier Plan November 2015 Formulary Updates desogestrel & ethinyl estradiol tab 0.15 mg-30 mcg RIVASTIGMINE DIS 13.3/24; QL (30 patches/30 days) RIVASTIGMINE DIS 4.6MG/24;

More information

2017 Medicare Part D Formulary Change

2017 Medicare Part D Formulary Change 2017 Medicare Part D Change We may add or remove drugs from our formulary during the year. If we remove drugs from our formulary, or add prior authorizations, quantity limits and/or step therapy restrictions

More information

2018 CareOregon Advantage Part D Formulary Changes

2018 CareOregon Advantage Part D Formulary Changes 2018 CareOregon Advantage Part D Formulary Changes Abbreviations: AGE = Age Restriction; PA = Prior Authorization Required; QL = Quantity Limit; ST = Step Therapy Required; LD = Limited Distribution; BvD

More information

FORMULARY UPDATES TO DENVER HEALTH MEDICAID CHOICE (DHMC) AND CHILD HEALTH PLAN PLUS (CHP+) PLANS

FORMULARY UPDATES TO DENVER HEALTH MEDICAID CHOICE (DHMC) AND CHILD HEALTH PLAN PLUS (CHP+) PLANS FORMULARY UPDATES TO DENVER HEALTH MEDICAID CHOICE (DHMC) AND CHILD HEALTH PLAN PLUS (CHP+) PLANS DHMC/CHP+ may add or remove drugs from the formulary or make changes to restrictions on formulary drugs

More information

Upper Peninsula Health Plan Advantage (HMO) (H ) Updates

Upper Peninsula Health Plan Advantage (HMO) (H ) Updates February, 2017 02/28/2017 abacavirlamivudine 02/28/2017 abacavirlamivudine 02/28/2017 rasagiline mesylate 02/28/2017 rasagiline mesylate abacavir sulfate/lamivudine ADD UM: QUANTITY 30 / 30 Days abacavir

More information

March 2017 Pharmacy & Therapeutics Committee Decisions

March 2017 Pharmacy & Therapeutics Committee Decisions UCare s Pharmacy and Therapeutics Committee (P&T) is a group of physicians and pharmacists that meet throughout the year to make changes to the UCare formulary (approved drug list). These changes are reviewed

More information

Notice of Mid-Year Changes to 2019 Paramount Enhanced Formulary

Notice of Mid-Year Changes to 2019 Paramount Enhanced Formulary Notice of Mid-Year s to 2019 Paramount Enhanced Formulary Paramount Elite (HMO) may immediately remove a brand name drug on our List if we are replacing it with a new generic drug that will appear on the

More information

FORMULARY UPDATES TO DENVER HEALTH MEDICAID CHOICE (DHMC) AND CHILD HEALTH PLAN PLUS (CHP+) PLANS

FORMULARY UPDATES TO DENVER HEALTH MEDICAID CHOICE (DHMC) AND CHILD HEALTH PLAN PLUS (CHP+) PLANS FORMULARY UPDATES TO DENVER HEALTH MEDICAID CHOICE (DHMC) AND CHILD HEALTH PLAN PLUS (CHP+) PLANS DHMC/CHP+ may add or remove drugs from the formulary or make changes to restrictions on formulary drugs

More information

Pharmacy and Therapeutics (P&T) Committee Provider Update

Pharmacy and Therapeutics (P&T) Committee Provider Update Pharmacy and Therapeutics (P&T) Committee Provider Update THIRD QUARTER 2017 Presbyterian Health Plan, Inc. Presbyterian Insurance Company, Inc. P&T Committee Decisions Effective August 15, 2017 Dear Healthcare

More information

NOTIFICATION OF FORMULARY CHANGES

NOTIFICATION OF FORMULARY CHANGES NOTIFICATION OF CHANGES The following summary describes changes to the 2018 Presbyterian Senior Care (HMO)/(HMO-POS), Presbyterian MediCare PPO and formularies. The formulary may change at any time. You

More information

Medicare Part D 2016 Formulary Changes Desert Preferred Choice

Medicare Part D 2016 Formulary Changes Desert Preferred Choice Medicare Part D 2016 Formulary s Desert Preferred Choice Inter Valley Health Plan may add or remove drugs from our formulary during the year. If we remove a drug from our formulary, add prior authorization,

More information

2018 Medicare Part D Formulary Change

2018 Medicare Part D Formulary Change 2018 Medicare Part D Formulary Change We may add or remove drugs from our formulary during the year. If we remove drugs from our formulary, or add prior authorizations, quantity limits and/or step therapy

More information

2019 Drug List Negative Changes

2019 Drug List Negative Changes 2019 Drug List Negative Changes Updated 03/26/2019 If you are taking a drug that is removed from the formulary (also known as the Drug List), we will tell you. We will also tell you if we add any restrictions

More information

2018 Formulary Update

2018 Formulary Update MEDICARE ADVANTAGE BlueShield of Northeastern New York 2018 Formulary Update BlueShield of Northeastern New York has updated its formulary (drug list) since its original publication in January 2018. This

More information

Aetna Better Health of Illinois Medicaid Formulary Updates

Aetna Better Health of Illinois Medicaid Formulary Updates October 2017 o DOXYLAMINE SUCCINATE 25mg-QL o DULOXETINE CAP 40MG DR-QL o GUANFACIN ER TABS (all strengths)-ql o TOBRAMYCIN NEBU SOLUTION- PA August 2017 Aetna Better Health of Illinois Medicaid 2017 Formulary

More information

Alameda Alliance for Health Pharmacy & Therapeutics (P&T) Committee Decisions

Alameda Alliance for Health Pharmacy & Therapeutics (P&T) Committee Decisions Alameda Alliance for Health FORMULARY UPDATE Effective: October 27, 2017. Drugs notated with an * have an undetermined implementation date Alameda Alliance for Health Pharmacy & Therapeutics (P&T) Committee

More information

Quarterly Pharmacy Formulary Change Notice

Quarterly Pharmacy Formulary Change Notice MEDICAID PROVIDER BULLETIN February 26, 2015 Quarterly Pharmacy Formulary Change Notice Summary of Change: The formulary changes listed in the table below were reviewed and approved at our September 24,

More information

Health Partners Medicare Prime and Value (2017) Updates

Health Partners Medicare Prime and Value (2017) Updates March/April 2017 Effective Date Brand Name Name Type of Change Previous Value New Value SPS sodium polystyrene sulfonate/sorbitol solution ORKAMBI ADRENACLICK ADRENACLICK levalbuterol tartrate hfa EXONDYS

More information

Reason for change. Recently approved. Recently approved. Recently approved. Recently approved. Recently updated. Recently approved.

Reason for change. Recently approved. Recently approved. Recently approved. Recently approved. Recently updated. Recently approved. 2017 Formulary Change Notice Please note these changes to your 2017 List of Covered Drugs Drug name (medication) Rubraca Aprepitant Onivyde Oseltamivir Restasis Xiidra Daptomycin Selzentry Linzess Butalb/APAP/caff

More information

PRESCRIPTION DRUG PROGRAM FORMULARY UPDATES Select Formulary October 1, 2018 Updates. Formulary. Alternatives

PRESCRIPTION DRUG PROGRAM FORMULARY UPDATES Select Formulary October 1, 2018 Updates. Formulary. Alternatives PRESCRIPTION DRUG PROGRAM FORMULARY UPDATES Select October 1, 2018 Updates Drug Name efavirenz 600mg (Brand = Sustiva ) trientine (Brand = Syprine ) hydrocortisone lot 0.1% (Brand = Locoid ) sumatriptan-naproxen

More information

2019 Drug List Negative Changes

2019 Drug List Negative Changes 2019 Drug List Negative Changes Updated 03/26/2019 If you are taking a drug that is removed from the formulary (also known as the Drug List), we will tell you. We will also tell you if we add any restrictions

More information

HEALTH SHARE/PROVIDENCE (OHP)

HEALTH SHARE/PROVIDENCE (OHP) HEALTH SHARE/PROVIDENCE (OHP) STEP THERAPY This is a complete list of drugs that have written coverage determination policies. Drugs on this list do not indicate that this particular drug will be covered

More information

DPP4 INHIBITORS. Details. Step Therapy Criteria Health Alliance Plan 2019 Date Effective: 04/01/2019

DPP4 INHIBITORS. Details. Step Therapy Criteria Health Alliance Plan 2019 Date Effective: 04/01/2019 DPP4 INHIBITORS Janumet 50 mg-1,000 mg tablet Januvia 50 mg tablet Janumet 50 mg-500 mg tablet Onglyza 2.5 mg tablet Januvia 100 mg tablet Onglyza 5 mg tablet Januvia 25 mg tablet Tradjenta 5 mg tablet

More information

DPP4 INHIBITORS. Products Affected Step 2: Janumet 50 mg-1,000 mg tablet Janumet 50 mg-500 mg tablet Januvia 100 mg tablet Januvia 25 mg tablet

DPP4 INHIBITORS. Products Affected Step 2: Janumet 50 mg-1,000 mg tablet Janumet 50 mg-500 mg tablet Januvia 100 mg tablet Januvia 25 mg tablet DPP4 INHIBITORS Janumet 50 mg-1,000 mg tablet Janumet 50 mg-500 mg tablet Januvia 100 mg tablet Januvia 25 mg tablet Januvia 50 mg tablet Onglyza 2.5 mg tablet Onglyza 5 mg tablet Tradjenta 5 mg tablet

More information

Developing a Oncology Treatment Resource for Claims-Based Research: Innovation with Medications

Developing a Oncology Treatment Resource for Claims-Based Research: Innovation with Medications Developing a Oncology Treatment Resource for Claims-Based Research: Innovation with Medications Donna R. Rivera, PharmD., MSc. Scientific Project Officer and Pharmacist Surveillance Informatics Branch

More information

Quarterly pharmacy formulary change notice

Quarterly pharmacy formulary change notice Quarterly pharmacy formulary change notice Summary of change: The Pharmacy and Therapeutics Committee (P&T) reviewed and approved the formulary changes listed in the table below on March 29, 2016. What

More information

Superior Select Health Plans: Tribute-1 Tier May 2018 Formulary Addendum

Superior Select Health Plans: Tribute-1 Tier May 2018 Formulary Addendum Superior Select Health Plans: Tribute-1 Tier May 2018 Formulary Addendum Below is a list formulary changes for the benefit year 2018. This is not a complete list of drugs covered by the Part D plan. The

More information

Prescription benefit updates Large group

Prescription benefit updates Large group Prescription benefit updates Large group Moda Health s prescription program is a pharmacy benefit that offers members a choice of safe effective medication treatments. The program also helps you save money

More information

Health Partners Medicare Prime and Value (2017) Updates

Health Partners Medicare Prime and Value (2017) Updates March/April 2017 Effective Date Brand Name Name Type of Change Previous Value New Value SPS sodium polystyrene sulfonate/sorbitol solution ORKAMBI ADRENACLICK ADRENACLICK levalbuterol tartrate hfa EXONDYS

More information

5-ASA. Products Affected DIPENTUM 250 MG CAPSULE LIALDA 1.2 GRAM TABLET,DELAYED RELEASE. Details

5-ASA. Products Affected DIPENTUM 250 MG CAPSULE LIALDA 1.2 GRAM TABLET,DELAYED RELEASE. Details 5-ASA DIPENTUM 250 MG CAPSULE LIALDA 1.2 GRAM TABLET,DELAYED You are required to have previous therapy with balsalazide, Delzicol, Apriso, or Asacol HD before we will cover Lialda or Dipentum. 1 ANTIEMETICS

More information

5-ASA. Products Affected. Details. Dipentum 250 mg capsule. Lialda 1.2 gram tablet,delayed release

5-ASA. Products Affected. Details. Dipentum 250 mg capsule. Lialda 1.2 gram tablet,delayed release Updated 11/1/17 5-ASA Dipentum 250 mg capsule Lialda 1.2 gram tablet,delayed release You are required to have previous therapy with balsalazide, Delzicol, Apriso, or Asacol HD before we will cover Lialda

More information

Quarterly Pharmacy Formulary Change Notice

Quarterly Pharmacy Formulary Change Notice Quarterly Pharmacy Formulary Change Notice Summary of Change: The formulary changes listed in the table below were reviewed and approved at our December 18, 2014 Value Assessment Committee (VAC) meeting.

More information

DIABETES (1 of 5) Generic. Generic $0 $5 $5-10 $0 $0 $0. Generic $0 $5 $5-10. Generic. Generic $0 $5 $5-10 $0 $0 $0. Generic $0 $5 $5-10 $0 $0 $0

DIABETES (1 of 5) Generic. Generic $0 $5 $5-10 $0 $0 $0. Generic $0 $5 $5-10. Generic. Generic $0 $5 $5-10 $0 $0 $0. Generic $0 $5 $5-10 $0 $0 $0 Metformin DIABETES (1 of 5) Glucophage Glucophage XR ER $7 (500mg) $7 (500mg) $5 $5 500mg, 750mg only 500mg, 750mg only Sulfonylurea/Combinations Amaryl Glucotrol glimepiride glipizide $5 $5 Glucotrol

More information

FORMULARY LIST OF COVERED DRUGS

FORMULARY LIST OF COVERED DRUGS FORMULARY LIST OF COVERED DRUGS 2018 PLEASE READ: THIS DOCUMENT CONTAINS INFORMATION ABOUT THE DRUGS WE COVER IN THIS PLAN. HPMS Approved Formulary File Submission ID 00018248, Version Number #3 This formulary

More information

GHC-SCW Mandated Coverage Alphabetical Index Last Updated 8/1/2018

GHC-SCW Mandated Coverage Alphabetical Index Last Updated 8/1/2018 Search Tip: This is a large document, but you can search quickly and easily by clicking on the binocular icon on your toolbar. It will then display a search box for you to type in the name of the drug

More information

Blue Cross and Blue Shield of Minnesota GenRx Formulary Updates

Blue Cross and Blue Shield of Minnesota GenRx Formulary Updates Blue Cross and Blue Shield of Minnesota GenRx Formulary Updates July 2018 TRADE NAME (generic name) or generic name ADVAIR DISKUS (fluticasone-salmeterol aer powder ba 100-50 mcg/dose) Brand Addition ADVAIR

More information

Changes to the 2018 MHC CO-OP Preferred Drug List

Changes to the 2018 MHC CO-OP Preferred Drug List Changes to the 2018 MHC CO-OP Preferred Drug List MHC CO-OP Individual & Small Group Plans may add or remove drugs from the Drug List during the year. If a drug is scheduled to be removed from the Drug

More information

PDP Classic Formulary Addendum

PDP Classic Formulary Addendum PDP Classic Formulary Addendum The following medications have been added to the WellCare formulary as of March 2009. Drug Name Therapeutic Class Drug Tier Requirements/Limits Changes Made acetazolamide

More information

Added, Removed or Changed. Date of Change. No Change

Added, Removed or Changed. Date of Change. No Change One mission: you s September 7, 2017 Blue Cross of Idaho reviews its formularies (covered drug lists) periodically to allow members access to new drugs and to provide safe, cost effective options for your

More information

Pharmacy and Therapeutics (P&T) Committee Provider Update

Pharmacy and Therapeutics (P&T) Committee Provider Update Pharmacy and Therapeutics (P&T) Committee Provider Update FIRST QUARTER 2017 P&T Committee Decisions effective March 1, 2017 Dear Healthcare Practitioner: The Presbyterian Health Plan, Inc., and Presbyterian

More information

Quarterly pharmacy formulary change notice

Quarterly pharmacy formulary change notice Quarterly pharmacy formulary change notice Provider update Summary: The formulary changes listed in the table below were reviewed and approved at our second quarter 2018, Pharmacy and Therapeutics Committee

More information

Alprazolam 0.25mg, 0.5mg, 1mg tablets

Alprazolam 0.25mg, 0.5mg, 1mg tablets Presbyterian Senior Care (HMO) / Presbyterian MediCare PPO Quantity Limits Effective November 1, 2014 For the most recent list of drugs or other questions, please contact the Presbyterian Customer Service

More information

Quarterly pharmacy formulary change notice

Quarterly pharmacy formulary change notice Provider Bulletin April 2018 This table is used by HealthKeepers, Inc. to indicate formulary changes applicable to all Anthem HealthKeepers Plus members. These changes were reviewed and approved at the

More information

WellCare Signature (PDP) and WellCare Classic (PDP) Formulary Addendum

WellCare Signature (PDP) and WellCare Classic (PDP) Formulary Addendum WellCare Signature (PDP) and WellCare Classic (PDP) Formulary Addendum This is a listing of the changes that have occurred in our formulary. Please carefully review these changes and call WellCare if you

More information

5-ASA. Products Affected Dipentum 250 mg capsule. Details. Lialda 1.2 gram tablet,delayed release

5-ASA. Products Affected Dipentum 250 mg capsule. Details. Lialda 1.2 gram tablet,delayed release 5-ASA Dipentum 250 mg capsule Lialda 1.2 gram tablet,delayed release You are required to have previous therapy with balsalazide, Delzicol, Apriso, or Asacol HD before we will cover Lialda or Dipentum.

More information

Health Partners Medicare Prime 2019 Formulary Changes

Health Partners Medicare Prime 2019 Formulary Changes Health Partners Medicare Prime 2019 Formulary Changes Changes occur, for example, because new drugs come on the market, a drug is moved to a different cost-sharing level (tier), or a generic version becomes

More information

Department of Public Safety and Correctional Services

Department of Public Safety and Correctional Services Department of Public Safety and Correctional Services Office of the Secretary 300 E. JOPPA ROAD SUITE 1000 TOWSON, MARYLAND 21286-3020 (410) 339-5000 FAX (410) 339-5071 TOLL FREE (877) 379-8636 V/TTY (800)

More information

Pharmacologic Agents for Treatment of Type 2 Diabetes

Pharmacologic Agents for Treatment of Type 2 Diabetes Pharmacologic Agents for Treatment of Type 2 Diabetes SCAN Drugs Medication Biguanides 1 1 er uncoated tabs 500 mg & 750 mg Sulfonylureas 1 1 500 850 mg QD - TID 500 2000 mg glimepiride 1 1 1 8 mg glipizide

More information

Quarterly pharmacy formulary change notice

Quarterly pharmacy formulary change notice Provider Bulletin June 24, 2016 Summary of change The Pharmacy and Therapeutics Committee reviewed and approved the formulary changes listed in the table below on March 29, 2016. What this means to you

More information

Pharmacy Updates Summary

Pharmacy Updates Summary All of the following changes were reviewed and approved by the SFHP Pharmacy & Therapeutics (P&T) Committee on 7/16/2014 Effective date: 8/15/2014 Therapeutic Classes reviewed: Hepatitis C Ophthalmic Prostaglandins

More information

PHOTOFRIN Porfimer ALL LOB: ADD NF PA FETZIMA Levomilnacipran 20-40mg Titration pack ALL LOB: Add NF with PA

PHOTOFRIN Porfimer ALL LOB: ADD NF PA FETZIMA Levomilnacipran 20-40mg Titration pack ALL LOB: Add NF with PA March 24, 2014 Subject: February 13, 2014 LA Care PT&T Updates Dear Practitioner: We would like to thank you for providing quality services to our LA Care Medi-Cal (LAC01), Healthy Kids (LAC02), Healthy

More information

THERAPEUTIC AREA NAME STRENGTH DOSAGE FORM

THERAPEUTIC AREA NAME STRENGTH DOSAGE FORM Value Based Tier Drugs are selected for the management of Asthma, Diabetes, Hypertension and Hyperlipidemia. These drugs are covered at no charge or at a reduced cost share. Medications are under continual

More information

STEP THERAPY CRITERIA

STEP THERAPY CRITERIA STEP THERAPY This is a complete list of drugs that have written coverage determination policies. Drugs on this list do not indicate that this particular drug will be covered under your medical or prescription

More information

ANGIOTENSIN RECEPTOR BLOCKERS

ANGIOTENSIN RECEPTOR BLOCKERS Step Therapy 2014 2 Tier-Alameda Last Updated: 10/10/2014 ANGIOTENSIN RECEPTOR BLOCKERS Benicar Benicar Hct Diovan Valsartan Step 1: First line therapy should be irbesartan, irbesartan/hctz, losartan,

More information

PRIOR AUTHORIZATION BYPASS Tanzeum (albiglutide) Bypass the Prior Authorization by Modifying the following Prescription Forms to the Patient's Needs

PRIOR AUTHORIZATION BYPASS Tanzeum (albiglutide) Bypass the Prior Authorization by Modifying the following Prescription Forms to the Patient's Needs Please ote: Medical ecessity Prior Authorization may be overrided for both formulary coverage and benefit design restrictions. They are issued at the full discretion of the benefit manager. PRIOR AUTHORIZATIO

More information

PRIOR AUTHORIZATION BYPASS Bydureon (long acting exenatide)

PRIOR AUTHORIZATION BYPASS Bydureon (long acting exenatide) Please ote: Medical ecessity Prior Authorization may be overrided for both formulary coverage and benefit design restrictions. They are issued at the full discretion of the benefit manager. PRIOR AUTHORIZATIO

More information

FORMULARY CHANGE NOTICE 2008 JULY

FORMULARY CHANGE NOTICE 2008 JULY FORMULARY CHANGE NOTICE 2008 JULY Drug Name Dosage Form Strength Alternative Medicine* Formulary Formulary Change and Reason Status of Alternative Medication Updated Status On Formulary STARLIX TABS 120MG

More information

UPDATE WellCare s New Jersey

UPDATE WellCare s New Jersey UPDATE WellCare s New Jersey Preferred Drug List July 13, 2015 Dear Provider: At the June 04, 2015 WellCare Pharmacy & Therapeutics Committee meeting, it was decided that the following changes will be

More information

Health New England Medicare Advantage 2019 Formulary (List of Covered Drugs) HMO & HMO/POS

Health New England Medicare Advantage 2019 Formulary (List of Covered Drugs) HMO & HMO/POS Health New England Medicare Advantage 2019 Formulary (List of Covered Drugs) HMO & HMO/POS A comprehensive list of the brand name and generic medications that your Health New England Medicare Advantage

More information

Health New England Medicare Advantage 2018 Formulary (List of Covered Drugs) HMO

Health New England Medicare Advantage 2018 Formulary (List of Covered Drugs) HMO Health New England Medicare Advantage 2018 Formulary (List of Covered Drugs) HMO A comprehensive list of the brand name and generic medications that your Health New England Medicare Advantage plan covers.

More information

FORMULARY LIST OF COVERED DRUGS

FORMULARY LIST OF COVERED DRUGS FORMULARY LIST OF COVERED DRUGS 2017 PLEASE READ: THIS DOCUMENT CONTAINS INFORMATION ABOUT THE DRUGS WE COVER IN THIS PLAN. HPMS Approved Formulary File Submission ID 00017274, Version Number 6 This formulary

More information

2017 Formulary (List of Covered Drugs)

2017 Formulary (List of Covered Drugs) 017 Formulary (List of Covered Drugs) Liberty Health Advantage Preferred Choice (HMO) PLEASE READ: THIS DOCUMENT CONTAINS INFORMATION ABOUT THE DRUGS WE COVER IN THIS PLAN HPMS Approved Formulary File

More information

Plan Year CCHP Senior Program (HMO) Step Therapy Criteria (ST)

Plan Year CCHP Senior Program (HMO) Step Therapy Criteria (ST) Plan Year 2016 CCHP Senior Program (HMO) Step Therapy Criteria (ST) Step Therapy: In some cases, CCHP Senior Program (HMO) requires you to first try certain drugs to treat your medical condition before

More information

Michigan Department of Community Health Quantity Limitations

Michigan Department of Community Health Quantity Limitations Abstral (fentanyl) sl tab all strength Acetaminophen Actonel Actonel 35mg Adderall XR 5mg, 10mg, 15mg 240 per 34 days 3 gm/day 2 every 28 days 4 every 28 days Advair Diskus. No more than 180 every 30 days

More information

Subject: HPN/SHL COMMERCIAL PDL UPDATES EFFECTIVE JANUARY 1, 2018

Subject: HPN/SHL COMMERCIAL PDL UPDATES EFFECTIVE JANUARY 1, 2018 Date: November 7, 2017 To: From: HPN/SHL Contracted Pharmacies and Providers Ryan Bitton, PharmD, MBA Senior Director, Pharmacy Subject: HPN/SHL COMMERCIAL PDL UPDATES EFFECTIVE JANUARY 1, 2018 Effective

More information

Type 2 Diabetes: Where Do We Start with Treatment? DIABETES EDUCATION. Diabetes Mellitus: Complications and Co-Morbid Conditions

Type 2 Diabetes: Where Do We Start with Treatment? DIABETES EDUCATION. Diabetes Mellitus: Complications and Co-Morbid Conditions Diabetes Mellitus: Complications and Co-Morbid Conditions ADA Guidelines for Glycemic Control: 2016 Retinopathy Between 2005-2008, 28.5% of patients with diabetes 40 years and older diagnosed with diabetic

More information

Quarterly pharmacy formulary change notice

Quarterly pharmacy formulary change notice Quarterly pharmacy formulary change notice The formulary changes listed in the table below were reviewed and approved at our second quarter 2018 Pharmacy and Therapeutics Committee meeting. Effective October

More information

ALBUTEROL - SCORE. Products Affected. Details. Step Therapy Criteria Farm Bureau Health Plans Date Effective: November 1, 2018.

ALBUTEROL - SCORE. Products Affected. Details. Step Therapy Criteria Farm Bureau Health Plans Date Effective: November 1, 2018. ALBUTEROL - SCORE Ventolin Hfa Trial of ProAir Formulary ID 18351, Version 15 1 ANTIDEPRESSANTS - SCORE Desvenlafaxine Er TB24 100MG, 50MG Emsam Fetzima Fetzima Titration Pack Trial of two of the following

More information

ALABAMA S ADAP FORMULARY OFFERS 117 MEDICATIONS

ALABAMA S ADAP FORMULARY OFFERS 117 MEDICATIONS ALABAMA S ADAP FORMULARY OFFERS 117 MEDICATIONS - 2014 Alabama s ADAP formulary offers a minimum of one medication from each HIV antiretroviral class approved by the U.S. Food and Drug Administration (FDA).

More information

Step Therapy Medications

Step Therapy Medications Step Therapy Medications Step Therapy Group APTIOM Step-2: APTIOM 200 MG TABLET or APTIOM 400 MG TABLET or APTIOM 600 MG TABLET or APTIOM 800 MG TABLET Step 1 Drug(s): Oxcarbazepine immediate-release,

More information

ANTICONVULSANT STEP THERAPY

ANTICONVULSANT STEP THERAPY 2019 First Choice VIP Care Plus Formulary Document: 2019 Step Therapy Formulary ID: 19391 Last Updated: 2/2019 Effective Date: 03-01-2019 ANTICONVULSANT STEP THERAPY APTIOM 200 MG APTIOM 400 MG APTIOM

More information

Capital BlueCross Open/Closed Formulary Update (1 st Quarter 2017)

Capital BlueCross Open/Closed Formulary Update (1 st Quarter 2017) Capital BlueCross Open/Closed Formulary Update (1 st Quarter 2017) The Capital BlueCross formulary is a reference list of prescription drugs that contains a wide range of generic and brand drugs that have

More information

FARXIGA (dapagliflozin) Jardiance (empagliflozin) tablets. Synjardy (empagliflozin and metformin hydrochloride) tablets. GLUCOPHAGE* (metformin)

FARXIGA (dapagliflozin) Jardiance (empagliflozin) tablets. Synjardy (empagliflozin and metformin hydrochloride) tablets. GLUCOPHAGE* (metformin) Type 2 Medications Drug Class How It Works Brand and Generic Names Manufacturers Usual Starting Dose The kidneys filter sugar and either absorb it back into your body for energy or remove it through your

More information